Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 mRNA Vaccine And Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global mRNA Vaccine And Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global mRNA Vaccine And Therapeutics Overall Market Size
2.1 Global mRNA Vaccine And Therapeutics Market Size: 2022 VS 2030
2.2 Global mRNA Vaccine And Therapeutics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top mRNA Vaccine And Therapeutics Players in Global Market
3.2 Top Global mRNA Vaccine And Therapeutics Companies Ranked by Revenue
3.3 Global mRNA Vaccine And Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 mRNA Vaccine And Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies mRNA Vaccine And Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 mRNA Vaccine And Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 mRNA Vaccine And Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 mRNA Vaccine And Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global mRNA Vaccine And Therapeutics Market Size Markets, 2022 & 2030
4.1.2 Infectious Disease
4.1.3 Cancer
4.1.4 Others
4.2 By Type - Global mRNA Vaccine And Therapeutics Revenue & Forecasts
4.2.1 By Type - Global mRNA Vaccine And Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global mRNA Vaccine And Therapeutics Revenue, 2024-2030
4.2.3 By Type - Global mRNA Vaccine And Therapeutics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global mRNA Vaccine And Therapeutics Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Research Institual
5.2 By Application - Global mRNA Vaccine And Therapeutics Revenue & Forecasts
5.2.1 By Application - Global mRNA Vaccine And Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global mRNA Vaccine And Therapeutics Revenue, 2024-2030
5.2.3 By Application - Global mRNA Vaccine And Therapeutics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global mRNA Vaccine And Therapeutics Market Size, 2022 & 2030
6.2 By Region - Global mRNA Vaccine And Therapeutics Revenue & Forecasts
6.2.1 By Region - Global mRNA Vaccine And Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global mRNA Vaccine And Therapeutics Revenue, 2024-2030
6.2.3 By Region - Global mRNA Vaccine And Therapeutics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America mRNA Vaccine And Therapeutics Revenue, 2018-2030
6.3.2 US mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.3.3 Canada mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.3.4 Mexico mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe mRNA Vaccine And Therapeutics Revenue, 2018-2030
6.4.2 Germany mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.4.3 France mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.4.4 U.K. mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.4.5 Italy mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.4.6 Russia mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.4.7 Nordic Countries mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.4.8 Benelux mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia mRNA Vaccine And Therapeutics Revenue, 2018-2030
6.5.2 China mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.5.3 Japan mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.5.4 South Korea mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.5.5 Southeast Asia mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.5.6 India mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America mRNA Vaccine And Therapeutics Revenue, 2018-2030
6.6.2 Brazil mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.6.3 Argentina mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa mRNA Vaccine And Therapeutics Revenue, 2018-2030
6.7.2 Turkey mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.7.3 Israel mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.7.4 Saudi Arabia mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.7.5 UAE mRNA Vaccine And Therapeutics Market Size, 2018-2030
7 mRNA Vaccine And Therapeutics Companies Profiles
7.1 Argos Therapeutics
7.1.1 Argos Therapeutics Company Summary
7.1.2 Argos Therapeutics Business Overview
7.1.3 Argos Therapeutics mRNA Vaccine And Therapeutics Major Product Offerings
7.1.4 Argos Therapeutics mRNA Vaccine And Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Argos Therapeutics Key News & Latest Developments
7.2 BioNTech
7.2.1 BioNTech Company Summary
7.2.2 BioNTech Business Overview
7.2.3 BioNTech mRNA Vaccine And Therapeutics Major Product Offerings
7.2.4 BioNTech mRNA Vaccine And Therapeutics Revenue in Global Market (2018-2023)
7.2.5 BioNTech Key News & Latest Developments
7.3 CureVac
7.3.1 CureVac Company Summary
7.3.2 CureVac Business Overview
7.3.3 CureVac mRNA Vaccine And Therapeutics Major Product Offerings
7.3.4 CureVac mRNA Vaccine And Therapeutics Revenue in Global Market (2018-2023)
7.3.5 CureVac Key News & Latest Developments
7.4 eTheRNA
7.4.1 eTheRNA Company Summary
7.4.2 eTheRNA Business Overview
7.4.3 eTheRNA mRNA Vaccine And Therapeutics Major Product Offerings
7.4.4 eTheRNA mRNA Vaccine And Therapeutics Revenue in Global Market (2018-2023)
7.4.5 eTheRNA Key News & Latest Developments
7.5 Ethris
7.5.1 Ethris Company Summary
7.5.2 Ethris Business Overview
7.5.3 Ethris mRNA Vaccine And Therapeutics Major Product Offerings
7.5.4 Ethris mRNA Vaccine And Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Ethris Key News & Latest Developments
7.6 In-Cell-Art
7.6.1 In-Cell-Art Company Summary
7.6.2 In-Cell-Art Business Overview
7.6.3 In-Cell-Art mRNA Vaccine And Therapeutics Major Product Offerings
7.6.4 In-Cell-Art mRNA Vaccine And Therapeutics Revenue in Global Market (2018-2023)
7.6.5 In-Cell-Art Key News & Latest Developments
7.7 Moderna Therapeutics
7.7.1 Moderna Therapeutics Company Summary
7.7.2 Moderna Therapeutics Business Overview
7.7.3 Moderna Therapeutics mRNA Vaccine And Therapeutics Major Product Offerings
7.7.4 Moderna Therapeutics mRNA Vaccine And Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Moderna Therapeutics Key News & Latest Developments
7.8 Sangamo Therapeutics
7.8.1 Sangamo Therapeutics Company Summary
7.8.2 Sangamo Therapeutics Business Overview
7.8.3 Sangamo Therapeutics mRNA Vaccine And Therapeutics Major Product Offerings
7.8.4 Sangamo Therapeutics mRNA Vaccine And Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Sangamo Therapeutics Key News & Latest Developments
7.9 Tiba Biotechnology
7.9.1 Tiba Biotechnology Company Summary
7.9.2 Tiba Biotechnology Business Overview
7.9.3 Tiba Biotechnology mRNA Vaccine And Therapeutics Major Product Offerings
7.9.4 Tiba Biotechnology mRNA Vaccine And Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Tiba Biotechnology Key News & Latest Developments
7.10 Translate Bio
7.10.1 Translate Bio Company Summary
7.10.2 Translate Bio Business Overview
7.10.3 Translate Bio mRNA Vaccine And Therapeutics Major Product Offerings
7.10.4 Translate Bio mRNA Vaccine And Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Translate Bio Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer